The Waxing, Waning, and Predictors of Humoral Responses to Vector-Based SARS-CoV-2 Vaccine in Hemodialysis Patients

Hemodialysis (HD) patients are vulnerable to coronavirus disease 2019 (COVID-19) and have a high mortality rate. We evaluated the anti-SARS-CoV-2 spike protein antibody (ACOV2S) levels in 385 HD patients before and 4 and 8 weeks after the second dose of vector-based ChAdOx1 nCoV-19 vaccine. For stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Chung-Ming, Tsai, Kai-Fan, Kuo, Wei-Hung, Wu, Chien-Hsing, Yu, Ching-I, You, Huey-Ling, Lee, Chien-Te
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502593/
https://www.ncbi.nlm.nih.gov/pubmed/36146615
http://dx.doi.org/10.3390/vaccines10091537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502593/
https://www.ncbi.nlm.nih.gov/pubmed/36146615
http://dx.doi.org/10.3390/vaccines10091537

Ejemplares similares